Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce G Pollock

Showing results (61-70 of 327) with videos related to

Pageof 33
Sort By:
Therapeutic Drug Monitoring|January 28, 2003
A preliminary study of the effect of fluoxetine treatment on the 2:16-alpha-hydroxyestrone ratio in young womenDiane S Thompson, Margaret A Kirshner, Thomas L Klug, et al.
Assessment|November 16, 2019
A Hierarchical Integration of Normal and Abnormal Personality Dimensions: Structure and Predictive Validity in a Heterogeneous Sample of Psychiatric OutpatientsTimothy A Allen, Colin G DeYoung, R Michael Bagby, et al.
Psychosomatics|January 8, 2004
Plasma levels of citalopram in depressed patients with hepatitis COndria C Gleason, William R Yates, Michelle A Philipsen, et al.
Journal of Psychiatry & Neuroscience : JPN|March 12, 2008
Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patientsFrancis E Lotrich, Bruce G Pollock, Margaret Kirshner, et al.
Journal of Clinical Pharmacology|November 15, 2006
The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activityRyan M Carnahan, Brian C Lund, Paul J Perry, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 1, 2006
Paroxetine treatment of primary insomnia in older adultsCharles F Reynolds, Daniel J Buysse, Mark D Miller, et al.
The Journal of ECT|October 23, 2010
Transient insight induction with electroconvulsive therapy in a patient with refractory schizophrenia: a case report and systematic literature reviewPhilip Gerretsen, Pablo Diaz, David Mamo, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 20, 2009
Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanismsHiroyuki Uchida, Shitij Kapur, Benoit H Mulsant, et al.
Schizophrenia Research|April 14, 2015
Challenging the need for sustained blockade of dopamine D₂ receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A single-blind, randomized, controlled studyTakashi Tsuboi, Takefumi Suzuki, Robert R Bies, et al.
The American Journal of Psychiatry|August 31, 2002
Interrater reliability in clinical trials of depressive disordersBenoit H Mulsant, Kari B Kastango, Jules Rosen, et al.
Pageof 33

Showing results (61-70 of 327) with videos related to

Sort By:
Pageof 33
Therapeutic Drug Monitoring|January 28, 2003
A preliminary study of the effect of fluoxetine treatment on the 2:16-alpha-hydroxyestrone ratio in young womenDiane S Thompson, Margaret A Kirshner, Thomas L Klug, et al.
Assessment|November 16, 2019
A Hierarchical Integration of Normal and Abnormal Personality Dimensions: Structure and Predictive Validity in a Heterogeneous Sample of Psychiatric OutpatientsTimothy A Allen, Colin G DeYoung, R Michael Bagby, et al.
Psychosomatics|January 8, 2004
Plasma levels of citalopram in depressed patients with hepatitis COndria C Gleason, William R Yates, Michelle A Philipsen, et al.
Journal of Psychiatry & Neuroscience : JPN|March 12, 2008
Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patientsFrancis E Lotrich, Bruce G Pollock, Margaret Kirshner, et al.
Journal of Clinical Pharmacology|November 15, 2006
The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activityRyan M Carnahan, Brian C Lund, Paul J Perry, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 1, 2006
Paroxetine treatment of primary insomnia in older adultsCharles F Reynolds, Daniel J Buysse, Mark D Miller, et al.
The Journal of ECT|October 23, 2010
Transient insight induction with electroconvulsive therapy in a patient with refractory schizophrenia: a case report and systematic literature reviewPhilip Gerretsen, Pablo Diaz, David Mamo, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 20, 2009
Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanismsHiroyuki Uchida, Shitij Kapur, Benoit H Mulsant, et al.
Schizophrenia Research|April 14, 2015
Challenging the need for sustained blockade of dopamine D₂ receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A single-blind, randomized, controlled studyTakashi Tsuboi, Takefumi Suzuki, Robert R Bies, et al.
The American Journal of Psychiatry|August 31, 2002
Interrater reliability in clinical trials of depressive disordersBenoit H Mulsant, Kari B Kastango, Jules Rosen, et al.
Pageof 33